COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,757 Articles (22,502 medRxiv, 8,255 bioRxiv)

Most recent first Previous |  Page 848: Articles 8471-8480  | Next

Rapid hypermutation B cell trajectory recruits previously primed B cells upon third SARS-CoV-2 mRNA vaccination
Paschold, L., Klee, B., Gottschick, C., Willscher, E., Diexer, S., Schultheiss, C., Simnica, D., Sedding, D., Girndt, M., Gekle, M., Mikolajczyk, R., Binder, M.
10.1101/2022.03.01.482462 — Posted: 2022-03-02
Flipped Over U: Structural Basis for dsRNA Cleavage by the SARS-CoV-2 Endoribonuclease
Frazier, M. N., Wilson, I. M., Krahn, J. M., Butay, K. J., Dillard, L. B., Borgnia, M. J. N., Stanley, R. E.
10.1101/2022.03.02.480688 — Posted: 2022-03-02
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening
Roy, A., Alhammad, Y. M., McDonald, P., Johnson, D. K., Zhuo, J., Wazir, S., Ferraris, D. V., Lehtiö, L., Leung, A., Fehr, A. R.
10.1101/2022.03.01.482536 — Posted: 2022-03-02
Development and validation of a quantitative instrument for measuring temporal and social disorientation in the Covid-19 crisis
Fernandez Velasco, P., Gurchani, U., Perroy, B., Pelletreau-Duris, T., Casati, R.
10.1101/2022.02.28.22270969 — Posted: 2022-03-02
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and signs of neurodegeneration: a prospective cross-sectional study
Etter, M. M., Martins, T., Kulsvehagen, L., Poessnecker, E., Duchemin, W., Hogan, S., Diaz, G. S., Mueller, J., Chiappini, A., Rychen, J., Eberhard, N., Melie-Garcia, L., Keller, E., Jelcic, I., Siegemund, M., Pargger, H., Kuhle, J., Oechtering, J., Eich, C., Tzankov, A., Matter, M., Yaldizli, O., Lieb, J., Psychogios, M. N., Berkemeier, C., Leuzinger, K., Hirsch, H., Granziera, C., Proebstel, A.-K., Hutter, G.
10.1101/2022.02.18.22271039 — Posted: 2022-03-02
Descriptive and Narrative Study of Long Covid Cases in General Practice and Diagnostic Value of Single Photon Emission Computed Tomography
JAMOULLE, M., Kazeneza-Mugisha, G., zayane, A.
10.1101/2022.03.01.22270897 — Posted: 2022-03-02
Comparing Waves of COVID-19 in the US: Scale of response changes over time
Richards, R. L., Foster, G., Elderd, B. D., Dallas, T. A.
10.1101/2022.03.01.22271713 — Posted: 2022-03-02
Variability in SARS-Cov-2 IgG Antibody Affinity To Omicron and Delta Variants in Convalescent and Community mRNA Vaccinated Individuals
Tu, M., Chiang, S. H., Wong, D., Strom, C.
10.1101/2022.03.01.22271665 — Posted: 2022-03-02
In vitro Characterization of SARS-CoV-2 Protein Translated from the Moderna mRNA-1273 Vaccine
Veenstra, T., Injeti, E., Pauley, B.
10.1101/2022.03.01.22271618 — Posted: 2022-03-02
Racial/Ethnic Disparities in the Observed COVID-19 Case Fatality Rate Among the U.S. Population
Schumm, L. P., Giurcanu, M. C., Locey, K. J., Ortega, J. C., Zhang, Z., Grossman, R. L.
10.1101/2022.03.01.22271708 — Posted: 2022-03-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).